New Myasthenia Gravis Playbook Pairs Fast-Acting Antibody Blockers With Long-Term Immune Therapies
Seven real-world cases from a Greek neuromuscular center show how FcRn antagonists, rituximab and ravulizumab can be sequenced in generalized ...
Seven real-world cases from a Greek neuromuscular center show how FcRn antagonists, rituximab and ravulizumab can be sequenced in generalized ...
A global pharmacovigilance analysis of 354 pregnancies found no unexpected safety signals with the complement inhibitor ravulizumab, with outcomes consistent ...
A new Nature Reviews Neurology review details how the complement system drives autoimmune and neurodegenerative neurological diseases and how a ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine